Hong Kong Cancer Institute

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Hong Kong Cancer Institute

The Hong Kong Cancer Institute was established in 1990 to resolve the problems related to cancer and its side effects. The main aim of this institute is to coordinate, promote and organize all the activities relating to prevention, management and treatment of cancer. It also promotes and provides training in cancer research and takes initiatives to educate the public on the methods of prevention and treatment of cancer. It also organizes symposiums, workshops, seminars and conferences to improve its objectives. Most of the institute’s researches and other activities are carried out at Sir Yue-kong Pao Centre for Cancer located at the Prince of Wales Hospital, which was officially established on 7th November, 1994. The centre provides clinical and counseling services through a pediatric oncology ward, out-patient and day-patient facilities for adults, and a comprehensive range of diagnostic facilities.
With a generous fund from Hong Kong Cancer Fund, Cancer Patient Research Center has been established in the institute in 2003. Cancer Patient Research Center is managed by the Chinese University and the hospital authority. It is executed by Mrs. Betty Tung. It also has other directors namely Mrs. Sally Lo and Dr. Ko Wing Man. The centre provides an Oasis of Calm for cancer patients undergoing treatment in the Cancer Centre and also a venue suitable for conducting research in the psychosocial aspects of cancer care.
Different laboratories conduct various functions in Cancer center independently. The Hong Kong Cancer Institute provides the framework to foster the inter departmental collaborative activities. It also received central allocation grant for its extensive research on functional genomics in Hepatocellular carcinoma and viral genomics in Hepatitis B virus. Other researches in this institute include Biology and Diagnostic Applications of Plasma Nucleic Acids, Molecular Genetics of Glioma, Cancer Epigenetics, Biomedical Mass Spectrometry, Nasopharyngeal Carcinoma Research, Orthopedics & Traumatology research, etc.